SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-227936
Filing Date
2018-07-26
Accepted
2018-07-26 17:11:04
Documents
5
Period of Report
2018-08-30
Effectiveness Date
2018-07-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d563728ddef14a.htm DEF 14A 415008
2 GRAPHIC g563728g15o49.jpg GRAPHIC 36467
3 GRAPHIC g563728g31e13.jpg GRAPHIC 20952
4 GRAPHIC g563728pc1a.jpg GRAPHIC 244573
5 GRAPHIC g563728pic2.jpg GRAPHIC 75651
  Complete submission text file 0001193125-18-227936.txt   931439
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32587 | Film No.: 18972481
SIC: 2834 Pharmaceutical Preparations